TACE surgery, also called hepatic artery chemoembolization, is a common minimally invasive treatment for liver cancer. It inserts a catheter selectively or super-selectively into the target artery supplying blood to the tumor, and injects an appropriate amount of embolic agent at an appropriate rate to embolize the artery, causing ischemia and necrosis. Then use anticancer drugs or drugs combined with particles and microspheres for embolization to play the role of chemotherapeutic embolization, which is known as TACE, and is mostly used in the treatment of hepatocellular carcinoma, including hepatic artery cannulation chemoembolization or hepatic artery cannulation perfusion chemotherapy.